NK

Nutan Khare

Active Director Director DIN 08915079
DIN 08915079 First appointment Oct 2020 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2020
Shareholding value •••• Premium profile

About Nutan Khare

Data last updated:

Nutan Khare is a Director at Dr Khare Hospital Private Limited (since 2020). The company operates in Healthcare. Dr Khare Hospital Private Limited reported revenue of ₹15.50 Cr (FY 2025).

DIN 08915079
Primary Designation Director
Industry Healthcare
First Appointment 12 Oct 2020
Oldest Company Age 6 yrs
Largest company Dr Khare Hospital Private Limited · ₹15.50 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Dr Khare Hospital Private Limited U85100UP2020PTC136067
Director12 Oct 20202020₹15.50 Cr (FY 2025)Active

Board colleagues of Nutan Khare

Directorship timeline

Open interactive timeline →
Dr Khare Hospital Private Limited
Premium access

Shareholding and investment profile for Nutan Khare

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nutan Khare

Nutan Khare currently holds 1 directorship: Dr Khare Hospital Private Limited (Director, since 12 Oct 2020, revenue ₹15.50 Cr (FY 2025)).

Nutan Khare was first appointed on 12 Oct 2020 as Director at Dr Khare Hospital Private Limited.

The current boards of Nutan Khare's companies include Ashish Naresh (Dr Khare Hospital Private Limited), Rakesh Khare (Dr Khare Hospital Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available